Although not statistically significant, the frequency of EGFR mutations was higher in Chinese (46.4%), in patients aged less than or equal to 60 years old (48.8%), in advanced stage patients (45.8%), in moderately differentiated tumour cells (47.6%), and in never smokers (68%). Here, EGFR is linked to neoplasm.